ArticleBMC cancer2023

Real-world effectiveness of third-line cabazitaxel in patients with metastatic castration-resistant prostate cancer: CARD-like analysis of data from a post-marketing surveillance in Japan.

Hideyasu Matsuyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.